Protamine–heparin complex antibodies raise concerns

Almost a third of patients treated with protamine for heparin reversal during cardiopulmonary bypass develop antibodies to circulating protamine–heparin complexes, study findings suggest.

Source: MedWire News - Cardiology - February 25, 2013 Category: Cardiology Source Type: news